Product Description
In 2021, the U.S. computer-guided surgery market size is projected to reach $40.5 million, with the surgical guide market showing the fastest growth. The total U.S. market size is expected to grow over the forecast period to exceed $68 million in 2027.
In the U.S, the target market for treatment planning software and surgical guides were general practitioners (GPs). However, in recent years, specialists have been purchasing treatment planning software and using surgical guides as a means of standardization. Originally, specialists focused on purchasing a small number of surgical guides to cater to their complex cases. However, now that surgical guides are more affordable, they are being used for a greater number of cases, even for specialists.
The U.S. market for treatment planning software is limited by third-party labs and software companies that provide the market with full-service outsourcing of the planning and surgical guide production, as opposed to investing in their own software. However, because GPs are placing more and more implants, investment in their own software is now more attractive.
Computer-Guided Surgery Market Share Insights
Within the U.S. computer-guided surgery markets, Dentsply Sirona, Anatomage, and Envista are the market leaders.
Dentsply Sirona leads the U.S. market for both surgical guides and treatment planning software. Following the merger between Dentsply International and Sirona Dental Systems in 2016, the resulting company has experienced significant growth in digital dentistry and related spaces. Both companies offered surgical guide products under the SIMPLANT®, SICAT®, and CEREC® brands. Dentsply Sirona continues to offer SIMPLANT® as the guided surgery product in its portfolio.
Anatomage is the second-leading company in the U.S. surgical guide market. The company offers a completely digital process for its guided surgery production. Unlike many of its competitors, Anatomage offers a flat fee per production, regardless of the number of implant sites involved.
On the other hand, Envista is the second-leading competitor in the U.S. treatment planning software market. Like Dentsply Sirona, Envista is a provider of premium implants. Its strong position in the dental implant market helped to drive sales of its treatment planning software, including its NobelClinican™ product line.
Computer-Guided Surgery Market Segmentation Summary
- Surgical Guide market | United States | 2021-2027 | Medcore – the market research is further segmented by
- Type: Traditional, Third-Party, and In-House Produced Surgical Guides.
- Treatment Planning Software Market | United States | 2021-2027 | Medcore – the in-depth analysis of the U.S. treatment planning software market including the projection on the maintenance fees.
Computer-Guided Surgery Market Data Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
ABOUT OUR IN-DEPTH MEDCORE RESEARCH
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment and provides further detailed segmentation to get a much more granular set of market data.
This MedCore research is also found in the full report suite titled Dental Implants & Final Abutments Market Analysis | United States | 2021-2027 | MedSuite
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
